Henshaw Capital LLC reduced its stake in shares of Envista Holdings Corporation (NYSE:NVST – Free Report) by 27.3% in the 1st quarter, Holdings Channel reports. The firm owned 56,073 shares of the company’s stock after selling 21,009 shares during the quarter. Henshaw Capital LLC’s holdings in Envista were worth $1,423,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Caitong International Asset Management Co. Ltd grew its position in shares of Envista by 16,711.1% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock valued at $31,000 after buying an additional 1,504 shares during the last quarter. Allworth Financial LP raised its position in shares of Envista by 75.4% during the fourth quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock worth $39,000 after acquiring an additional 776 shares during the last quarter. UMB Bank n.a. lifted its stake in shares of Envista by 46.1% in the fourth quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock worth $44,000 after acquiring an additional 636 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Envista by 73.1% in the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock worth $44,000 after acquiring an additional 949 shares during the period. Finally, IFP Advisors Inc boosted its holdings in Envista by 102.9% in the fourth quarter. IFP Advisors Inc now owns 2,112 shares of the company’s stock valued at $46,000 after acquiring an additional 1,071 shares during the last quarter.
Analyst Ratings Changes
A number of analysts have weighed in on NVST shares. Zacks Research downgraded shares of Envista from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 6th. Piper Sandler boosted their price target on shares of Envista from $25.00 to $26.00 and gave the stock a “neutral” rating in a research report on Wednesday. JPMorgan Chase & Co. upped their price objective on shares of Envista from $26.00 to $29.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. Evercore reiterated an “outperform” rating and set a $33.00 price objective on shares of Envista in a research report on Thursday, May 7th. Finally, Barclays lowered their target price on shares of Envista from $34.00 to $32.00 and set an “overweight” rating for the company in a research note on Thursday, June 11th. Six investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. According to MarketBeat, Envista presently has a consensus rating of “Hold” and an average price target of $28.62.
Envista Stock Performance
Shares of NVST stock opened at $27.39 on Friday. The firm has a 50 day moving average of $25.59 and a 200-day moving average of $25.89. The company has a market cap of $4.46 billion, a price-to-earnings ratio of 66.80, a price-to-earnings-growth ratio of 1.55 and a beta of 0.86. The company has a quick ratio of 2.06, a current ratio of 2.44 and a debt-to-equity ratio of 0.47. Envista Holdings Corporation has a 52 week low of $18.77 and a 52 week high of $30.42.
Envista (NYSE:NVST – Get Free Report) last released its earnings results on Wednesday, May 6th. The company reported $0.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.31 by $0.05. The company had revenue of $705.50 million for the quarter, compared to the consensus estimate of $680.03 million. Envista had a net margin of 2.41% and a return on equity of 7.11%. Envista’s quarterly revenue was up 14.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.24 EPS. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. On average, equities analysts forecast that Envista Holdings Corporation will post 1.42 earnings per share for the current year.
About Envista
Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.
Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.
See Also
- Five stocks we like better than Envista
- Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Corporation (NYSE:NVST – Free Report).
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.
